A. Valipour (Wien, Austria), A. Nyberg (Umeå, Sweden)
Late Breaking Abstract - Influence of omalizumab therapy on airway remodelling assessed with high-resolution computed tomography (HRCT) in severe allergic asthma patients
M. Przybyszowski (Krakow, Poland), K. Paciorek (Krakow, Poland), W. Zastrzezynska (Krakow, Poland), A. Gawlewicz-Mroczka (Krakow, Poland), A. Trojan-Krolikowska (Krakow, Poland), A. Orlowska (Krakow, Poland), J. Soja (Krakow, Poland), W. Pawlik (Krakow, Poland), K. Sladek (Krakow, Poland)
|     |
The two sides’ view of asthma-COPD overlap: a real life population approach.
N. Toledo Pons (Palma, Spain), J. Van Boven (Groningen, Netherlands), M. Román-Rodriguez (Palma, Spain), J. Valera (Palma, Spain), A. Millán Pons (Palma, Spain), B. Cosío (Palma, Spain)
| |
Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis
K. Ramsey (Chapel Hill, United States of America), G. Radicioni (Chapel Hill, United States of America), D. Hill (Chapel Hill, United States of America), C. Ehre (Chapel Hill, United States of America), B. Button (Chapel Hill, United States of America), N. Alexis (Chapel Hill, United States of America), M. Knowles (Chapel Hill, United States of America), S. Donaldson (Chapel Hill, United States of America), M. Kesimer (Chapel Hill, United States of America), M. Mcguckin (Brisbane, Australia), R. Boucher (Chapel Hill, United States of America)
| |
Associations between PCD-specific health-related quality of life (QOL-PCD) outcomes and clinical measures
H. Kobbernagel (Copenhagen, Denmark), F. Buchvald (Copenhagen, Denmark), L. Behan (Southampton, United Kingdom), J. Lucas (Southampton, United Kingdom), E. Haarman (Amsterdam, Netherlands), N. Rutjes (Amsterdam, Netherlands), A. Gross (Muenster, Germany), H. Omran (Muenster, Germany), C. Hogg (London, United Kingdom), C. Casaulta (Bern, Switzerland), C. Kuehni (Bern, Switzerland), S. Collins (Southampton, United Kingdom), M. Philipsen (Copenhagen, Denmark), A. Quittner (Coral Gables, Florida, United States of America), K. Nielsen (Copenhagen, Denmark)
| |
Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma
J. PATARIN (Grenoble, France), E. Ghiringhelli (Grenoble, France), C. Cracowski (Grenoble, France), B. Camara (Grenoble, France), S. Quetant (Grenoble, France), C. Bosc (Grenoble, France), C. Pison (Grenoble, France), J. Cracowski (Grenoble, France)
| |
Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms
K. Wang (Oxford, United Kingdom), J. Verbakel (Oxford, United Kingdom), A. Fleming-Nouri (Oxford, United Kingdom), J. Brewin (Oxford, United Kingdom), J. Oke (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), M. Thomas (Southampton, United Kingdom)
| |
Transforming growth factor-ß1 and Matrix Metalloproteinase-9 as factors of airway remodeling among asthmatic patients
V. Kmyta (Sumy, Ukraine), L. Prystupa (Sumy, Ukraine)
| |
The Inhaler Proficiency Score: a useful and valid tool for the assessment of good inhaler technique
B. Cushen (Dublin, Ireland), G. Greene (Dublin, Ireland), F. Lannon (Dublin, Ireland), S. Cowman (Bahrain, Bahrain), L. Mellon (Dublin, Ireland), R. Costello (Dublin, Ireland), E. Mac Hale (Dublin, Ireland)
| |
Clinical relevance of small airways assessment by lung function tests in asthma
C. Depoortère (Lille, France), T. Perez (Lille, France), C. Chenivesse (Lille, France), S. Fry (Lille, France)
| |
129Xenon-enhanced magnetic resonance imaging to understand particle exhalation from the human lung
O. Holz (Hannover , Germany), A. Kern (Hannover , Germany), H. Biller (Hannover, Germany), A. Olin (Gothenburg, Sweden), J. Vogel-Claussen (Hannover, Germany), J. Hohlfeld (Hannover, Germany)
| |
Comparison between Impulse oscillometry and Resmon Pro and the use of inspiratory parameters
L. Jarenbäck (Lund, Sweden), L. Bjermer (Lund, Sweden), E. Tufvesson (Lund, Sweden)
| |
FEV1/FEV3 ratio as an alternative to fixed ratio of FEV1/FVC
A. Bialas (Lodz, Poland), K. Kornicki (Lodz, Poland), M. Ciebiada (Lodz, Poland), J. Milkowska - Dymanowska (Lodz, Poland), W. Piotrowski (Lodz, Poland), A. Antczak (Lodz, Poland), P. Gorski (Lodz, Poland)
| |
Ordinal scales are not accurate to assess and measure respiratory rates in children
W. Daw (Sheffield, United Kingdom), R. Kingshott (Sheffield, United Kingdom), H. Elphick (Sheffield, United Kingdom)
| |
Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters
D. Dimitrova (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), T. Velikova (Sofia, Bulgaria), K. Tumangelova-Yuzeir (Sofia, Bulgaria)
| |
Biomarker-assisted characterisation of non-type 2 disease in young asthmatics
N. Tsolakis (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Alvin (Uppsala, Sweden)
| |
Blood eosinophils and exacerbation rate in COPD patients over three years
R. Prudente (Botucatu, Brazil), C. Mesquita (Botucatu, Brazil), R. Ferrari (Botucatu, Brazil), E. Franco (Botucatu, Brazil), S. Tanni (Botucatu, Brazil)
| |
Ergoreflex and the method of assessing the functional status in patients with COPD
I. Ponomareva (Ryazan, Russian Federation), A. Kosyakov (Ryazan, Russian Federation), V. Abrosimov (Ryazan, Russian Federation)
| |
Prognostic factors in severe eosinophilic asthma
F. Gonçalves Dos Santos Carvalho (Barcelona, Spain), C. Padró Casas (Barcelona, Spain), M. Basagaña Torrento (Barcelona, Spain), M. Rivera Ortun (Barcelona, Spain), M. Martínez Colls (Barcelona, Spain), C. Pollan Guisasola (Barcelona, Spain), A. Francoso Vicente (Barcelona, Spain), E. Martínez Cáceres (Barcelona, Spain), A. Teniente (Barcelona, Spain), A. Roger (Barcelona, Spain), J. Ruiz Manzano (Barcelona, Spain), C. Martinez Rivera (Barcelona, Spain)
| |